Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Artificial Intelligence Versus Clinical Examination in White Spot Lesions Detection, Identification, And Scoring

8 juni 2026 bijgewerkt door: Mohamed Hisham Abd ElFattah Gabr Ali, Cairo University

Diagnostic Accuracy of Artificial Intelligence Analysis Using Intraoral Photographs Versus Clinical Examination in White Spot Lesions Detection, Identification, And Scoring.

The goal of this observational study is to compare the diagnostic accuracy of Clinical examination as a standard for detection, identification and scoring of White Spot Lesions Versus Artificial intelligence analysis of intraoral photographs. The photographs are examined by experienced dental professionals to maintain diagnostic accuracy. Machine learning models YOLO and Mask-RCNN will analyze these images in three phases: pre-analytical, analytical and post-analytical. A dataset of 329 labelled photographs, annotated by experts, is used to train these models. Data augmentation methods enhance model performance, and accuracy is assessed against clinical examination results to confirm reliability.

The main question it aims to answer is:

- Is artificial intelligence analysis of intraoral photographs as accurate as clinical assessment in the detection, identification, and scoring of white spot lesions among adult Egyptian patients attending Cairo University Dental Hospital?

Studie Overzicht

Toestand

Nog niet aan het werven

Gedetailleerde beschrijving

Dentists frequently encounter various dental hard tissue anomalies that present both diagnostic challenges and require careful treatment planning. A common example is white spot lesions or whitish discolorations of the teeth that can arise from multiple etiologies. These may be carious in nature, such as post-orthodontic incipient caries, or represent developmental defects like dental fluorosis or molar-incisor hypo-mineralization (MIH). Distinguishing between these conditions is essential for appropriate clinical management. The diagnosis of WSLs primarily relies on visual and photographic examination, which evaluates the morphology, size, color, and location of the lesions. Depth assessment is particularly critical, as it serves as a key determinant in selecting the most appropriate treatment approach. Detection and scoring of WSLs can be accomplished through clinical visual inspection alone or enhanced by adjunctive diagnostic technologies, including laser fluorescence, quantitative light-induced fluorescence (QLF), and electrical impedance spectroscopy.

The clinical characteristics of WSLs can vary considerably, making differential diagnosis challenging. While specialist clinicians demonstrate high validity and reliability in distinguishing between various white spot lesions, general dental practitioners exhibit lower diagnostic accuracy. Conventional diagnostic approaches for white spot lesions often lack precision and consistency. Visual assessment presents several inherent limitations, including the potential for misclassification due to overlapping clinical presentations among different etiologies. A systematic review and meta-analysis examining the efficacy of detection methods for incipient caries reported that photographic visual inspection achieved a sensitivity of only 67% and specificity of 79%, highlighting the need for more reliable diagnostic approaches.

Recent advances in computing power, data accessibility, and processing capabilities have accelerated the development of artificial intelligence (AI) applications, transforming contemporary healthcare research. Dentistry has similarly benefited from this technological evolution, with AI demonstrating considerable potential across various clinical applications. Machine learning (ML), a subfield of AI, represents a powerful approach for computer-aided diagnostic support, with algorithms that identify patterns within datasets during training and apply this knowledge to make predictions on new data. Emerging evidence indicates that these AI advances can improve diagnostic accuracy in caries detection, thereby supporting clinicians in making more precise and reliable assessments. Dental photography, captured using devices such as DSLR cameras or intraoral cameras, serves as a valuable tool for diagnosis and treatment planning. When combined with intelligent image analysis methods, AI can automate the identification and assessment of diagnostic data from photographs, facilitating standalone diagnostic procedures that reduce subjectivity and enhance clinical decision-making. Deep CNNs can detect and distinguish entities of similar but not identical appearance when trained on sufficiently large image datasets. Employing such models as part of an integrated image-analysis software solution would enable rapid classification of existing photographic library data and improve the accuracy and reliability of clinicians' decision-making in treatment planning or referral. Emerging evidence from studies using intraoral photographs and AI algorithms demonstrates promising detection rates, with AI exhibiting high sensitivity, specificity, precision, accuracy, and reliability in diagnostic performance. AI-driven tools are designed to serve as supportive aids for clinicians, strengthening diagnostic accuracy, streamlining workflows, improving cost-efficiency, and enhancing patient care rather than replacing clinical expertise. Simplifying the diagnostic process for white spot lesions is essential to enable their timely detection at an early stage, facilitating prompt intervention and improving preventive outcomes. AI models must be validated using local data from diverse clinical settings, particularly in lower-middle-income countries, with their performance assessed through sensitivity, specificity, and accuracy measures and benchmarked against conventional diagnostic approaches. Therefore, it is crucial to develop and validate white spot lesion detection and classification models using data from Egyptian patients attending Cairo University Hospital to ensure accurate and clinically relevant results, emphasizing the potential improvements in accuracy and reliability that AI can bring to dental diagnostics.

Studietype

Observationeel

Inschrijving (Geschat)

329

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen

Accepteert gezonde vrijwilligers

Nee

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

Patients attending the Conservative Department of Cairo University Dental Clinic, aged from 20 to 60 years, presenting with white spot lesions of teeth, showing no signs or symptoms, demonstrating co-operation, and expressing interest in participating in the study will be considered eligible. Patients with orthodontic appliances or bridgework that could impact the clinical assessment process will be excluded.

Beschrijving

Inclusion Criteria:

  1. Adult patients aged 20 - 60 years
  2. Males or Females
  3. Patients with white spot lesions of teeth 4 - Co-operative patients with interest in participation in the study

Exclusion Criteria:

  1. Patients with orthodontic appliances or bridgework that might interfere with evaluation and assessment
  2. Patients with no white spot lesions
  3. Patients with systematic diseases that might affect participation
  4. Patients refusing to sign the informed consent or not willing to be part of the study

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Tijdsspanne
Artificial Intelligence diagnostic accuracy in White Spot Lesions Detection
Tijdsspanne: Baseline
Baseline

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Studie directeur: Asmaa A. Mohamed Yassen, Professor of Conservative Dentistry Department, Faculty of Dentistry, Cairo University
  • Studie directeur: Rawda Hesham Abdelaziz, Associate Professor of Conservative Dentistry Department, Faculty of Dentistry, Cairo University
  • Studie directeur: Asmaa A. Elsayed Osman, Lecturer of Information Technology, Faculty of Computers and Artificial Intelligence, Cairo University

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

1 juli 2026

Primaire voltooiing (Geschat)

1 juli 2027

Studie voltooiing (Geschat)

1 november 2027

Studieregistratiedata

Eerst ingediend

2 juni 2026

Eerst ingediend dat voldeed aan de QC-criteria

8 juni 2026

Eerst geplaatst (Werkelijk)

10 juni 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

10 juni 2026

Laatste update ingediend die voldeed aan QC-criteria

8 juni 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

ONBESLIST

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren